Crossfire Oncology
Pre-clinicalTransforming lives through innovative medicines. Aberrant functioning of kinases is known to be an important driver in cancer. Targeting hereof has proven to be extremely successful and has already revolutionized the management of numerous types of cancer. At Crossfire we approach kinases from three different angles:
Founded
2021
Focus
AntibodiesBiologicsSmall Molecules
About
Transforming lives through innovative medicines. Aberrant functioning of kinases is known to be an important driver in cancer. Targeting hereof has proven to be extremely successful and has already revolutionized the management of numerous types of cancer. At Crossfire we approach kinases from three different angles:
Funding History
1Total raised: $4.5M
Seed$4.5MBioGeneration VenturesSep 15, 2022
Company Info
TypePrivate
Founded2021
LocationUtrecht, Netherlands
StagePre-clinical
Contact
SIMILAR COMPANIES
2-BBB Medicines
Pre-clinical · Leiden
Batavia Biosciences
Pre-clinical · Leiden
Bilthoven Biologicals
Pre-clinical · Bilthoven
Agendia
Pre-clinical · Amsterdam
Alloksys Life Sciences
Phase 2 · Wageningen
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile